SARS-CoV-2 vaccine research and development: Conventional vaccines and biomimetic nanotechnology strategies

• Главные авторы: Lanxiang Huang (Автор), Yuan Rong (Автор), Qin Pan (Автор), Kezhen Yi (Автор), Xuan Tang (Автор), Qian Zhang (Автор), Wei Wang (Автор), Jianyuan Wu (Автор), Fubing Wang (Автор)
• Формат: ‌
• Опубликовано: Elsevier, 2021-03-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

The development of a massively producible vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential for stopping the current coronavirus disease (COVID-19) pandemic. A vaccine must stimulate effective antibody and T cell responses in vivo to indu...